Radiology was one of five specialties which spoke before the Meaningful Use Workgroup of the Office of the National Coordinator for Health Information Technology (ONC), in mid-May. It’s the first time the ONC invited a radiologist to formally participate in this advisory committee hearing.
Radiologists finally got their turn to tell the government what changes to make to the draft stage 2 meaningful use (MU) guidelines. Final versions of the guidelines will be submitted on June 8th. Radiology was one of five specialties which spoke before the Meaningful Use Workgroup of the Office of the National Coordinator for Health Information Technology (ONC), in mid-May.
It’s the first time the ONC invited a radiologist to formally participate in this advisory committee hearing. Representing radiologists was Keith Dreyer, DO, PhD, co-chair of the American College of Radiology's (ACR) IT and Informatics Committee and vice chair of imaging informatics at Massachusetts General Hospital. The committee wanted to hear about the electronic health record (EHR) experiences of these specialists in the real-world hospital and office environments - how they implemented and used electronic health records in patient care, measured performance and feedback, and how they used clinical decision support (CDS) systems. The information was solicited to help with their stage 2 and 3 deliberations on meaningful use (MU) objectives. The committee is not obligated to accept any of the proposals or suggestions.
Along with Dreyer, representatives from ophthalmology, pathology, surgery and immunology/allergy/asthma also spoke. Dreyer focused his testimony on imaging data access and exchange, appropriateness criteria-based CDS and the need for specialty-relevant MU measures.
“In terms of how EHRs can facilitate specialty care of patients, what immediately comes to my mind is that patients’ records must provide access to diagnostic images and related data,” Dreyer told the committee. “This access significantly benefits patients by reducing duplicative tests, thus reducing radiation exposure and healthcare costs.”
Dreyer recommended alternative MU criteria for radiologists, which would be more specific to that practice and thus more effective to the program goal.
“EHRs would facilitate specialty care much more efficiently if there were alternative MU measures and EHR certification requirements focused on improving imaging care,” said Dreyer. “CMS should allow radiologists to satisfy specialty objectives instead of other requirements that have no bearing on radiology practices.”
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.